Understanding the High Prevalence of Low-Prevalence Chronic Disease Combinations: Databases and Methods for Research. Appendix E – Key Informants

09/20/2013

Below is the list of key informants and their affiliations. Key informants were identified by the ASPE Project Officers and the Technical Advisory Group (TAG). Key informant interviews were conducted by telephone to provide the Project Team with in-depth expertise on topics covered in the White Paper. Findings from the Key Informant Interviews have been incorporated throughout the White Paper.

Key Informants

Richard Averill, MS

Senior Vice President of Clinical and Economic Research

3M Health Information Systems, Inc.

Allen Fremont, MD, PhD

Natural Scientist

Rand Corporation

Norbert Goldfied, MD

Medical Director

3M Health Information Systems, Inc.

Mary Goldstein, MD, MS

Professor of Medicine and of Health Research and Policy

VA Palo Alto Health Care System

Linda Magno, MA

Director, Medicare Demonstration Group

Centers for Medicare & Medicaid Services

Sally Okun, RN, MMHS

Vice President of Advocacy, Policy & Patient Safety

PatientsLikeMe

Yaffa Rubinstein, PhD

Program Director, Officer of Rare Diseases

National Institutes of Health

Jean Yoon, PhD

Health Economist, Health Economics Resource Center (HERC)

VA Palo Alto Healthcare System

 

View full report

Preview
Download

"rpt_LowPrevMCCData.pdf" (pdf, 1.37Mb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®